Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids for primary focal segmental glomerulosclerosis with moderate proteinuria
ChiCTR-OPN-17012789Phase 4Completed
- Sponsor
- Institute of Nephrology, Ruijin Hospital
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisone in focal segmental glomerulosclerosis (FSGS) (2 arms), sponsored by Institute of Nephrology, Ruijin Hospital. Primary endpoints: 24-hour urine protein, serum albumin and 1 more. Started Jun 2006; status: completed.
02
Drugs
prednisone
03
Conditions
focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on ChiCTR-OPN-17012789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17012789.